SCR-LIP-000635 · Claim · machine-readable JSON →
Some molecular profiling suggests local inflammatory pathways are downregulated in lipedema tissue, favouring metabolic over classical inflammatory mechanisms.
General proposition consolidated from 1 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (1)
- Defining lipedema's molecular hallmarks by multi-omics approach for disease prediction in women — Straub et al. (2025) ✓ verified — consistent · cross sectional · 2025 · reading confidence: high
“convergência das vias UPREGULADAS ('cellular respiration', 'oxidative phosphorylation', 'mitochondrial organization') e das DOWNREGULADAS ('immune effector process', 'leukocyte mediated immunity', 'innate immune response', 'inflammatory response')”
Multi-omics showed downregulated immune effector, innate immune and inflammatory response pathways with upregulated oxidative phosphorylation and mitochondrial pathways; minimal systemic inflammation; altered sphingolipids, glutamic acid and glutathione.
The study directly investigates molecular mechanisms in lipedema tissue using transcriptomics, proteomics, metabolomics, and lipidomics, providing specific findings about inflammation pathways; however, it is cross-sectional and observation
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000011